On October 26, 2021, we completed the initial public offering of 34,500,000 Units, at $10.00 per Unit, which included the full exercise by the underwriters of their over-allotment option in the amount of 4,500,000 Units, generating gross proceeds of $345,000,000.
Simultaneously with the closing of the initial public offering, the Company completed the private sale of an aggregate of 17,025,000 private placement warrants to our sponsor at a purchase price of $1.00 per private placement warrants, generating gross proceeds to the Company of $17,025,000.
A total of $353,625,000 of the proceeds from the initial public offering and the sale of the private placement warrants were placed in a U.S.-based trust account at J.P. Morgan Chase Bank, N.A. maintained by Continental Stock Transfer & Trust Company, acting as trustee.
Transaction costs of the initial public offering amounted to $16,966,617, consisting of $5,900,000 of underwriting discount, $10,325,000 of deferred underwriting discount, and $741,617 of actual offering costs. Of these amounts, $16,132,794 was recorded to additional paid-in capital and $833,823 costs related to the warrant liability was expensed immediately using the residual allocation method.
For the year ended December 31, 2022, net cash used in operating activities was $1,074,564. Net income of $18,512,854 was adjusted by $1,898,709 of unrealized gain on marketable securities held in trust, $3,201,980 of dividend income on marketable securities held in trust, and $15,337,600 change in fair value of warrant liability, and $850,871 of changes in operating assets.
As of December 31, 2022, we had marketable securities held in the trust account of $358,731,581 (including $1,898,709 of unrealized gains and $3,201,980 of dividend income) consisting of securities held in a money market fund that invests in U.S. Treasury securities with a maturity of 185 days or less.
As of December 31, 2022, we had cash of $599,286 held outside the trust account. We intend to use the funds held outside the trust account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a business combination.
We do not believe we will have sufficient funds in order to meet the expenditures required for operating our business prior to our initial business combination. We expect to incur significant costs related to identifying a target business, undertaking in-depth due diligence and negotiating an initial business combination. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of time within one year after the date that the financial statements are issued. In order to fund working capital deficiencies or finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete our initial business combination, we would repay such loaned amounts. In the event that our initial business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into warrants of the post business combination entity at a price of $1.00 per warrant at the option of the lender. The warrants would be identical to the private placement warrants. The terms of such loans, if any, have not been determined and no written agreements exist with respect to such loans. Prior to the completion of our initial business combination, we do not expect to seek loans from parties other than our sponsor or an affiliate of our sponsor as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account. If we have not consummated our initial Business Combination within the required time period, we will be forced to cease operations and liquidate the trust account.
On December 28, 2022, the Company issued the Convertible Promissory Note to the sponsor, pursuant to which the Company may borrow the Working Capital Loan from the sponsor for general corporate purposes. Such loan may, at the sponsor’s discretion, be converted into Working Capital Warrants, with each Working Capital Warrant entitling the Sponsor to purchase one Class A Share at a price of $11.50 per share, subject to the same adjustments applicable to the private placement warrants sold concurrently with the Company’s initial public offering. The Working Capital Loan will not bear any interest and will be repayable by the Company to the sponsor, if not converted or repaid on the effective date of an initial business combination. The maturity date of the Working Capital Loan may be accelerated upon the occurrence of an Event of Default (as defined under the Convertible Promissory Note). The Company granted customary registration rights to the sponsor with respect to any Working Capital Warrants and any Class A ordinary shares that may be issued upon exercise of any Working Capital Warrants. Such securities shall constitute “Registrable Securities” pursuant to that